Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP580175.RASZG-eLDIUbPzjkWfWHEvZI9WUewf-xy4ZxvvX7apfiA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP580175.RASZG-eLDIUbPzjkWfWHEvZI9WUewf-xy4ZxvvX7apfiA130_assertion type Assertion NP580175.RASZG-eLDIUbPzjkWfWHEvZI9WUewf-xy4ZxvvX7apfiA130_head.
- NP580175.RASZG-eLDIUbPzjkWfWHEvZI9WUewf-xy4ZxvvX7apfiA130_assertion description "[Although the clinical trials of Hsp90 inhibitors in breast cancer therapy are ongoing, the BCSC targeting effect of them remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP580175.RASZG-eLDIUbPzjkWfWHEvZI9WUewf-xy4ZxvvX7apfiA130_provenance.
- NP580175.RASZG-eLDIUbPzjkWfWHEvZI9WUewf-xy4ZxvvX7apfiA130_assertion evidence source_evidence_literature NP580175.RASZG-eLDIUbPzjkWfWHEvZI9WUewf-xy4ZxvvX7apfiA130_provenance.
- NP580175.RASZG-eLDIUbPzjkWfWHEvZI9WUewf-xy4ZxvvX7apfiA130_assertion SIO_000772 22445681 NP580175.RASZG-eLDIUbPzjkWfWHEvZI9WUewf-xy4ZxvvX7apfiA130_provenance.
- NP580175.RASZG-eLDIUbPzjkWfWHEvZI9WUewf-xy4ZxvvX7apfiA130_assertion wasDerivedFrom befree-20140225 NP580175.RASZG-eLDIUbPzjkWfWHEvZI9WUewf-xy4ZxvvX7apfiA130_provenance.
- NP580175.RASZG-eLDIUbPzjkWfWHEvZI9WUewf-xy4ZxvvX7apfiA130_assertion wasGeneratedBy ECO_0000203 NP580175.RASZG-eLDIUbPzjkWfWHEvZI9WUewf-xy4ZxvvX7apfiA130_provenance.